Atlas Trials

Graft-vs-Host Disease (GVHD)

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Graft-vs-Host Disease (GVHD)

RecordFirmDate
Treatment of Refractory (Acute or Chronic) Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem Cell (NCT00447460)University of Salamanca2007-01-01
Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant (NCT00088543)Genzyme, a Sanofi Company2004-03-01

Track Graft-vs-Host Disease (GVHD) automatically

Every clearance here is in the API, with alerts when new ones post.